The regenerative potential of bone marrow following exposure to relati
vely high doses of ionizing radiation, as well as the efficacy of hemo
poietic growth factor treatment, are dependent on the residual number
of hemopoietic stem cells. From studies in mice in particular, evidenc
e has been obtained that immature hemopoietic stem cells are heterogen
ous with respect to repopulating capacity, with one subset being capab
le of short-term, transient hemopoietic reconstitution and another sub
set of sustained reconstitution. In rhesus monkeys, CD34(+), RhLA-DR(d
ull) cells were identified as the small fraction of a bone marrow cell
that contains reconstituting hemopoietic stem cells. The growth facto
r receptor phenotype of this immature cell fraction has been determine
d for granulocyte-macrophage colony-stimulating factor (GM-CSF), inter
leukin 3 (IL-3), and IL-6 as well as for kit-ligand, making c-kit an e
specially strong growth factor receptor marker for reconstituting stem
cells. In addition, it is demonstrated that CD34(+) cells appear in p
eripheral blood after exposure to radiation and are correlated to numb
ers of CD34(+) cells in bone marrow. This finding suggests that circul
ating CD34(+) cells may be used as a cellular marker with prognostic s
ignificance for both the number of residual stem cells as well as rege
neration of immature hemopoietic cells in bone marrow.